elivaldogene autotemcel (eli-cel; Skysona)
Jump to navigation
Jump to search
Indications
- early, active cerebral adrenoleukodystrophy
Adverse effects
- cases of myelodysplastic syndrome & acute myeloid leukemia
Mechanism of action
More general terms
References
- ↑ George J FDA Investigating Blood Cancer Risk With Gene Therapy Skysona. Agency is evaluating the need for further regulatory action MedPage Today November 27, 2024 https://www.medpagetoday.com/neurology/generalneurology/113164